Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brinzolamide/Brimonidine Fixed Combination vs Components in Glaucoma or Ocular Hypertension
NCT02339584Phase 3Completed
- Sponsor
- Alcon Inc.
- Start
- Apr 2015
- Primary completion
- Nov 2016
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of brinzolamide and brimonidine tartrate + sodium hyaluronate in open-angle glaucoma (OAG) and ocular hypertension (2 arms), sponsored by Alcon Inc. Primary endpoint: Mean Diurnal IOP Change From Baseline at Month 3. Started Apr 2015; status: completed.
02
Drugs
brinzolamidebrimonidine tartrate + sodium hyaluronate
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT02339584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02339584.